Pharmacokinetic Properties of ORM-14540 and ORM-12741 After Administration of a Microdose of 14C-Labelled Drug; An Open, Non-Randomised, Single Dose, Single Centre Study in Healthy Male Subjects.

Trial Profile

Pharmacokinetic Properties of ORM-14540 and ORM-12741 After Administration of a Microdose of 14C-Labelled Drug; An Open, Non-Randomised, Single Dose, Single Centre Study in Healthy Male Subjects.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs ORM 12741; ORM 14540
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Feb 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 03 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top